Teva reaches settlement in ProAir patent case
Teva has reached a settlement in its patent battle with two pharmaceutical companies, ending all litigation over its ProAir HFA (albuterol sulfate) inhalation aerosol.
Victory for Bayer as CJEU grants safeners extra protection
Europe’s highest court has said that products used by agrochemical companies to help maintain plants can be given extended patent protection.
Holland & Knight nabs life sciences litigator
Holland & Knight LLP has expanded its IP practice group with the hire of patent litigator Howard Suh as partner.
Canada and Australia in new stem cell partnership
Stem cell research companies in Canada and Australia have teamed up to support increased research and development in both countries.
Merck to acquire Idenix for $3.85bn
Drug giant Merck is to acquire biopharmaceutical company Idenix for $24.50 per share, valuing the purchase at around $3.85 billion.
Actavis and Zydus settle Asacol patent dispute
Irish-based drug manufacturer Actavis has settled its patent dispute with Zydus Pharmaceuticals.
Dechert hires life sciences partner in Frankfurt
Law firm Dechert LLP has appointed Rüdiger Herrmann as a partner in its Frankfurt office.
Ferumoxytol patent extended by USPTO
AMAG Pharmaceuticals, Inc. has had a US patent covering ferumoxytol extended.
Kite Pharma enters into licensing agreement with NIH
Kite Pharma, a biotech company, has entered into a licensing agreement with the US’s National Institute of Health that will give it the IP rights to T-cell therapies developed to treat cancer.
Pharma report calls for “wide debate” in Europe
Pharmaceutical professionals should have a “wide-ranging” debate on how IP can be tailored in the face of “major changes” to the industry, including the possibility of “prolonged exclusivity” for certain medicines, according to a report.
